Six‐gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation-Reference-Cited by-同舟云学术

Six‐gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation

Published:2019-02-18 Issue:4 Volume:13 Page:781-791
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Shou Xin¹,Li Yong²,Hu Weilei¹,Ye Tingting¹,Wang Guosheng¹,Xu Feng²,Sui Meihua³,Xu Yibing¹

Affiliation:

1. Institute of Translational Medicine Zhejiang University School of Medicine Hangzhou China

2. Department of Medical Oncology Shanghai Gongli Hospital Second Military Medical University Shanghai China

3. Center for Cancer Biology and Innovative Therapeutics Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province Clinical Research Institute Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12427

Reference34 articles.

1. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients

2. Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.

3. Liquid Biopsies, What We Do Not Know (Yet)